breast cancer Archives - Elixi International

25 October 2021

Trodelvy (sacituzumab govitecan), First-in-class medicine to treat aggressive form of breast cancer

5 January 2021

Ibrance, Palbociclib, is the #1 prescribed, FDA-approved oral combination treatment for HR+, HER2- mBC.

18 April 2020

Tukysa (tucatinib) new option of treatment of adult patients with advanced forms of HER2-positive breast cancer

15 January 2020

Enhertu (fam-trastuzumab deruxtecan-nxki), new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

9 January 2020

Lynparza (olaparib), already licensed for breast and ovarian cancer,it’s set to become the world’s first precision medicine for prostate cancer.